Pills Profits And Politics
Download Pills Profits And Politics full books in PDF, epub, and Kindle. Read online free Pills Profits And Politics ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
| Author | : Milton M. Silverman |
| Publisher | : University of California Press |
| Total Pages | : 422 |
| Release | : 2021-05-28 |
| Genre | : Business & Economics |
| ISBN | : 0520368738 |
This title is part of UC Press's Voices Revived program, which commemorates University of California Press’s mission to seek out and cultivate the brightest minds and give them voice, reach, and impact. Drawing on a backlist dating to 1893, Voices Revived makes high-quality, peer-reviewed scholarship accessible once again using print-on-demand technology. This title was originally published in 1974.
| Author | : Milton Silverman |
| Publisher | : Univ of California Press |
| Total Pages | : 426 |
| Release | : 1974 |
| Genre | : Drug traffic |
| ISBN | : 9780520030503 |
| Author | : Milton M. Silverman |
| Publisher | : Univ of California Press |
| Total Pages | : 422 |
| Release | : 2023-04-28 |
| Genre | : Business & Economics |
| ISBN | : 0520328906 |
This title is part of UC Press's Voices Revived program, which commemorates University of California Press’s mission to seek out and cultivate the brightest minds and give them voice, reach, and impact. Drawing on a backlist dating to 1893, Voices Revived makes high-quality, peer-reviewed scholarship accessible once again using print-on-demand technology. This title was originally published in 1974.
| Author | : Milton Silverman |
| Publisher | : Univ of California Press |
| Total Pages | : 428 |
| Release | : 1974-01-01 |
| Genre | : Business & Economics |
| ISBN | : 9780520026162 |
A report on misrepresentation and irresponsibility in the prescription drug industry
| Author | : Milton Morris Silverman |
| Publisher | : |
| Total Pages | : 403 |
| Release | : 1976 |
| Genre | : |
| ISBN | : |
| Author | : Steven Brill |
| Publisher | : Random House |
| Total Pages | : 528 |
| Release | : 2015-01-05 |
| Genre | : History |
| ISBN | : 0812996968 |
NEW YORK TIMES BESTSELLER • A NEW YORK TIMES NOTABLE BOOK • “A tour de force . . . a comprehensive and suitably furious guide to the political landscape of American healthcare . . . persuasive, shocking.”—The New York Times America’s Bitter Pill is Steven Brill’s acclaimed book on how the Affordable Care Act, or Obamacare, was written, how it is being implemented, and, most important, how it is changing—and failing to change—the rampant abuses in the healthcare industry. It’s a fly-on-the-wall account of the titanic fight to pass a 961-page law aimed at fixing America’s largest, most dysfunctional industry. It’s a penetrating chronicle of how the profiteering that Brill first identified in his trailblazing Time magazine cover story continues, despite Obamacare. And it is the first complete, inside account of how President Obama persevered to push through the law, but then failed to deal with the staff incompetence and turf wars that crippled its implementation. But by chance America’s Bitter Pill ends up being much more—because as Brill was completing this book, he had to undergo urgent open-heart surgery. Thus, this also becomes the story of how one patient who thinks he knows everything about healthcare “policy” rethinks it from a hospital gurney—and combines that insight with his brilliant reporting. The result: a surprising new vision of how we can fix American healthcare so that it stops draining the bank accounts of our families and our businesses, and the federal treasury. Praise for America’s Bitter Pill “An energetic, picaresque, narrative explanation of much of what has happened in the last seven years of health policy . . . [Brill] has pulled off something extraordinary.”—The New York Times Book Review “A thunderous indictment of what Brill refers to as the ‘toxicity of our profiteer-dominated healthcare system.’ ”—Los Angeles Times “A sweeping and spirited new book [that] chronicles the surprisingly juicy tale of reform.”—The Daily Beast “One of the most important books of our time.”—Walter Isaacson “Superb . . . Brill has achieved the seemingly impossible—written an exciting book about the American health system.”—The New York Review of Books
| Author | : Donald Light |
| Publisher | : Columbia University Press |
| Total Pages | : 179 |
| Release | : 2010 |
| Genre | : Business & Economics |
| ISBN | : 0231146922 |
Few people realize that prescription drugs have become a leading cause of death, disease, and disability. Adverse reactions to widely used drugs, such as psychotropics and birth control pills, as well as biologicals, result in FDA warnings against adverse reactions. The Risks of Prescription Drugs describes how most drugs approved by the FDA are under-tested for adverse drug reactions, yet offer few new benefits. Drugs cause more than 2.2 million hospitalizations and 110,000 hospital-based deaths a year. Serious drug reactions at home or in nursing homes would significantly raise the total. Women, older people, and people with disabilities are least used in clinical trials and most affected. Health policy experts Donald Light, Howard Brody, Peter Conrad, Allan Horwitz, and Cheryl Stults describe how current regulations reward drug companies to expand clinical risks and create new diseases so millions of patients are exposed to unnecessary risks, especially women and the elderly. They reward developing marginally better drugs rather than discovering breakthrough, life-saving drugs. The Risks of Prescription Drugs tackles critical questions about the pharmaceutical industry and the privatization of risk. To what extent does the FDA protect the public from serious side effects and disasters? What is the effect of giving the private sector and markets a greater role and reducing public oversight? This volume considers whether current rules and incentives put patients' health at greater risk, the effect of the expansion of disease categories, the industry's justification of high U.S. prices, and the underlying shifts in the burden of risk borne by individuals in the world of pharmaceuticals. Chapters cover risks of statins for high cholesterol, SSRI drugs for depression and anxiety, and hormone replacement therapy for menopause. A final chapter outlines six changes to make drugs safer and more effective. Suitable for courses on health and aging, gender, disability, and minority studies, this book identifies the Risk Proliferation Syndrome that maximizes the number of people exposed to these risks. Additional Columbia / SSRC books on the privatization of risk and its implications for Americans: Bailouts: Public Money, Private ProfitEdited by Robert E. Wright Disaster and the Politics of InterventionEdited by Andrew Lakoff Health at Risk: America's Ailing Health System-and How to Heal ItEdited by Jacob S. Hacker Laid Off, Laid Low: Political and Economic Consequences of Employment InsecurityEdited by Katherine S. Newman Pensions, Social Security, and the Privatization of RiskEdited by Mitchell A. Orenstein
| Author | : Tom Nesi |
| Publisher | : Macmillan |
| Total Pages | : 317 |
| Release | : 2008-09-03 |
| Genre | : Business & Economics |
| ISBN | : 142993185X |
To the millions of Americans who suffer from chronic pain and arthritis, Vioxx seemed like a miracle. One of the most widely promoted and prescribed pain medications in the world -- used by more than twenty million people -- it was endorsed by the medical establishment and celebrities such as Olympic champion figure skater Dorothy Hamill. With annual sales of $2.5 billion, Vioxx became a pharmaceutical bonanza before being abruptly taken off the market in September 2004, after it was revealed that it led to an increased risk of heart-related disease and death. Drawing on internal documents, video footage, court testimony, and exclusive interviews, as well as three decades of experience inside the medical industry, Tom Nesi tells the dramatic story of what the drug's manufacturer, Merck, knew and when. It is a compelling narrative of business and medical science run amok, with a cast of characters ranging from those at the highest levels of the multibillion-dollar pharmaceutical industry to research scientists, marketers, and drug company sales reps. Here also are accounts from physicians, lawyers, financial analysts, and patients and their families whose lives have been forever altered by Vioxx. Set against a fascinating history of the origins of the modern pharmaceutical industry, POISON PILLS is a shocking tale that involves the breakdown of the United States medical system, the failures of the Food and Drug Administration, and enormous profits made by a large pharmaceutical corporation at the potential cost of thousands of lives.
| Author | : Antony Loewenstein |
| Publisher | : Scribe Publications |
| Total Pages | : 349 |
| Release | : 2019-08-21 |
| Genre | : Law |
| ISBN | : 1925693767 |
Like the never-ending war on terror, the drugs war is a multi-billion-dollar industry that won’t go down without a fight. Pills, Powder, and Smoke explains why. The war on drugs has been official American policy since the 1970s, with the UK, Europe, and much of the world following suit. It is at best a failed policy, according to bestselling author Antony Loewenstein. Its direct results have included mass incarceration in the US, extreme violence in different parts of the world, the backing of dictatorships, and surging drug addiction globally. And now the Trump administration is unleashing diplomatic and military forces against any softening of the conflict. Pills, Powder, and Smoke investigates the individuals, officials, activists, victims, DEA agents, and traffickers caught up in this deadly war. Travelling through the UK, the US, Australia, Honduras, the Philippines, and Guinea-Bissau, Loewenstein uncovers the secrets of the drug war, why it’s so hard to end, and who is really profiting from it. In reporting on the frontlines across the globe — from the streets of London’s King’s Cross to the killing fields of Central America to major cocaine transit routes in West Africa — Loewenstein reveals how the war on drugs has become the most deadly war in modern times. Designed and inspired by Washington, its agenda has nothing to do with ending drug use or addiction, but is all about controlling markets, territories, and people. Instead, Loewenstein argues, the legalisation and regulation of all drugs would be a much more realistic and humane approach. The evidence presented in this book will persuade many readers that he’s right.
| Author | : Milton M. Silverman |
| Publisher | : Univ of California Press |
| Total Pages | : 252 |
| Release | : 2023-04-28 |
| Genre | : Health & Fitness |
| ISBN | : 0520309804 |
If national health insurance becomes a reality, what options should be considered for the coverage of prescription drugs? The authors—whose Pills, Profits, and Politics has had a dramatic effect on physicians, pharmacists, patients, and the drug industry as well as on federal and state legislators—insist that the major objective must be the best possible health care. But holding down costs to patients and taxpayers must also be a goal. To complicate matters further, the advantage of each likely option—including price controls, the use of formularies, drug utilization review, patient cost-sharing, and the use of low-cost, generic-name products—is offset by a disadvantage, even a danger. If drug prices are slashed too much, the industry will lose many of its incentives to develop better drugs for the future. Particular attention is focused on the so-called drug lag—the lengthy delays in licensing of new drugs, even after they have been used with apparently good results in other countries. Pills and the Public Purse also addresses the seldom-appreciated fact that investing tax dollars in needed drugs may save taxpayers in the long run by minimizing unnecessary physician visits and hospitalization. Pills and the Public Purse challenges Congress and such agencies as the Food and Drug Administration and the Health Care Financing Administration to enact policies that put the interests of the public before those of government, industry, physicians, and pharmacists. This title is part of UC Press's Voices Revived program, which commemorates University of California Press’s mission to seek out and cultivate the brightest minds and give them voice, reach, and impact. Drawing on a backlist dating to 1893, Voices Revived makes high-quality, peer-reviewed scholarship accessible once again using print-on-demand technology. This title was originally published in 1981.
